Marie Zhu

Company: WuXi Biologics

Job title: Chief Technology Officer

Seminars:

Accelerating Novel ADC Development through WuXi XDC’s Innovative Technology & Integrated Development/Manufacturing Platform 5:30 pm

Learning how 5 of 13 approved ADCs use random cysteine conjugation with MMAE, capped at 2 mg/kg to avoid TEAEs  Discussing how WuXiDAR4's proprietary technology creates ADCs with a narrowly distributed DAR for enhanced efficacy and safety, eliminating the need to modify monoclonal antibodies or any enzymes, simplifying the process and reducing costs of goods …Read more

day: Day One PM